Phio Pharmaceuticals Corp. (PHIO)
0.808
+0.01
(+1.00%)
USD |
NASDAQ |
Nov 06, 09:51
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 9.387M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -49.37% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.7449 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.90% |
Profile
| Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the proprietary INTASYL® small interfering RNA gene silencing technology designed to make immune cells more effective in killing tumor cells. Its pipelines include PH-762 and PH-894. The company was founded on September 8, 2011 and is headquartered in King of Prussia, PA. |
| URL | http://www.phiopharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the proprietary INTASYL® small interfering RNA gene silencing technology designed to make immune cells more effective in killing tumor cells. Its pipelines include PH-762 and PH-894. The company was founded on September 8, 2011 and is headquartered in King of Prussia, PA. |
| URL | http://www.phiopharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |